東陽光(600673.SH):擬參與參股公司吸收合併
格隆匯7月10日丨東陽光(600673.SH)公佈,長江藥業與東陽光藥籤署了附生效條件的《吸收合併協議》,由東陽光藥向換股股東發行H股股份並註銷換股股東持有的長江藥業H股的方式吸收合併長江藥業,換股比例爲1:0.263614,即每1股會被註銷的長江藥業H股股票可以換得0.263614股東陽光藥發行的H股股票。
公司作爲東陽光藥、長江藥業的參股股東將參與本次合併換股事項,公司所持有的長江藥業21,815,200股H股股份預計可換得5,750,792股東陽光藥發行的H股股份(最終換股數量以實際交易情況爲準)。
東陽光藥根據有關法律法規及規則要求提出了本次換股方案,以吸收合併的方式將長江藥業私有化,據此,在先決條件及所有條件達成或獲豁免的前提下,由東陽光藥根據換股比率向全體換股股東發行H股,作爲換股的對價。目前,東陽光藥及長江藥業雙方簽署的《吸收合併協議》約定的前提條件已全部達成,將繼續推進合併、換股事項,而公司作爲長江藥業的換股股東,將參與本次換股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.